115.24 0.00 (0.00%)
After hours: 4:57PM EST
|Bid||109.75 x 300|
|Ask||0.00 x 0|
|Day's Range||113.46 - 115.63|
|52 Week Range||100.87 - 133.49|
|PE Ratio (TTM)||35.99|
|Earnings Date||Jan 29, 2018 - Feb 2, 2018|
|Forward Dividend & Yield||0.96 (0.85%)|
|1y Target Est||131.27|
On November 28, 2017, Howmedica Osteonics, an orthopedics subsidiary of Stryker (SYK) and Zimmer Biomet Holdings (ZBH), settled a trade secret case.
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Zimmer Biomet Holdings, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Zimmer Biomet Holdings, Inc. Here are 5 ETFs with the largest exposure to ZBH-US. Comparing the performance and risk of Zimmer Biomet Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Zimmer Biomet (ZBH) struggles with supply delay problem related to some of its products, causing inability to win back lost customers and gain new ones.
Categories: Yahoo FinanceGet free summary analysis Zimmer Biomet Holdings, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Zimmer Biomet Holdings, Inc. – Stryker Corporation, Johnson & Johnson, NuVasive, Inc., Exactech, Inc., Globus Medical, Inc. Class A, CONMED Corporation, RTI Surgical, Inc. and Wright Medical ... Read more (Read more...)
A new spine surgery robot has arrived on the scene to challenge Mazor's current dominance.
WARSAW, Ind., Nov. 21, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will participate in the 29th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace Hotel in New York City on November 28, 2017, at 4 p.m. EST. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.
Short interest is low for ZBH with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. The net inflows of $4.34 billion over the last one-month into ETFs that hold ZBH are among the lowest of the last year and appear to be slowing.
Zimmer Biomet Holdings (ZBH) ended trading at $108.70 on November 7, 2017. Currently, ZBH stock’s 50-day moving average stands at $117.60.
NEW YORK, Nov. 14, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of CalAtlantic ...
Zimmer Biomet Holdings (ZBH) made a downward revision to its 4Q17 and 2017 guidance in the company’s recent earnings release for 3Q17 on November 1, 2017.
Zimmer Biomet Holdings has laid down a dual sourcing strategy to resolve production issues at its Warsaw facility.
Zimmer Biomet Holdings witnessed a strong performance in its Asia-Pacific region. It contributed 16% to the company’s total sales.
Zimmer Biomet Holdings’ (ZBH) S.E.T. (Sports, Extremities, and Trauma) segment registered sales of $407 million, contributing 23% to the company’s total revenues.
In the quarter ended September 30, 2017, Zimmer Biomet Holdings (ZBH) registered a YoY (year-over-year) fall of 1.5% on a constant currency basis, excluding the impact of the LDR acquisition.
In 3Q17, Zimmer Biomet Holdings (ZBH) registered a YoY (year-over-year) sales growth of -1.5% on a constant currency basis.
Zimmer Biomet Holdings (ZBH) reported sales of approximately $1.8 billion in 3Q17, which ended on September 30, 2017. The company released its 3Q17 results on November 1, 2017.
WARSAW, Ind., Nov. 8, 2017 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that it will be participating in the Jefferies 2017 London Healthcare Conference on November 16, 2017, at 11:20 a.m. GMT (6:20 a.m. ET). Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare.